Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-025496
Filing Date
2020-04-23
Accepted
2020-04-23 20:24:57
Documents
2
Period of Report
2020-04-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2961
2 POA DOCUMENT poa.txt EX-24.3_911069 2467
  Complete submission text file 0001209191-20-025496.txt   6858
Mailing Address C/O FATE THERAPEUTICS, INC. 3535 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121
Business Address
Multani Pratik S (Reporting) CIK: 0001586894 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39269 | Film No.: 20812267

Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Issuer) CIK: 0001796280 (see all company filings)

EIN.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations